Tag: FDA guidance eConsent

Electronic Consent (eConsent) and Regulatory Expectations in Clinical Trials

Posted on digi By digi

Electronic Consent (eConsent) and Regulatory Expectations in Clinical Trials Understanding Electronic Informed Consent and Regulatory Expectations Introduction to eConsent Electronic informed consent (eConsent) is transforming how clinical trials manage participant consent. Unlike traditional paper forms, eConsent uses digital platforms—web-based portals, tablets, or mobile apps—to present information and capture participant signatures. Regulatory bodies such as the…

Read More “Electronic Consent (eConsent) and Regulatory Expectations in Clinical Trials” »

Clinical Trial Transparency and Ethics, Informed Consent Disclosure

Electronic Consent (eConsent) Tools and Validation in Clinical Trials

Posted on digi By digi

Electronic Consent (eConsent) Tools and Validation in Clinical Trials How to Implement and Validate Electronic Consent (eConsent) Tools in Clinical Trials As clinical trials evolve with technology, electronic informed consent—or eConsent—has become an essential tool for improving participant comprehension, accessibility, and compliance. However, the use of eConsent systems must be carefully managed to meet regulatory…

Read More “Electronic Consent (eConsent) Tools and Validation in Clinical Trials” »

Informed Consent and Ethics Committees, Informed Consent Process